Cargando…
Gastroprokinetic agent, mosapride inhibits 5-HT(3) receptor currents in NCB-20 cells
Mosapride accelerates gastric emptying by acting on 5-hydroxytryptamine type 4 (5-HT(4)) receptor and is frequently used in the treatment of gastrointestinal (GI) disorders requiring gastroprokinetic efficacy. We tested the effect of mosapride on 5-hydroxytryptamine type 3 (5-HT(3)) receptor current...
Autores principales: | Park, Yong Soo, Sung, Ki-Wug |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Physiological Society and The Korean Society of Pharmacology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717790/ https://www.ncbi.nlm.nih.gov/pubmed/31496879 http://dx.doi.org/10.4196/kjpp.2019.23.5.419 |
Ejemplares similares
-
Selective serotonin reuptake inhibitor escitalopram inhibits 5-HT(3) receptor currents in NCB-20 cells
por: Park, Yong Soo, et al.
Publicado: (2019) -
Lamotrigine, an antiepileptic drug, inhibits 5-HT(3) receptor currents in NCB-20 neuroblastoma cells
por: Kim, Ki Jung, et al.
Publicado: (2017) -
Tricyclic antidepressant amitriptyline inhibits 5-hydroxytryptamine 3 receptor currents in NCB-20 cells
por: Park, Yong Soo, et al.
Publicado: (2018) -
Physiologically-Based Pharmacokinetic and Pharmacodynamic Modeling for the Inhibition of Acetylcholinesterase by Acotiamide, A Novel Gastroprokinetic Agent for the Treatment of Functional Dyspepsia, in Rat Stomach
por: Yoshii, Kazuyoshi, et al.
Publicado: (2015) -
Mosapride-Induced Movement Disorders
por: Hong, Sang-Wook, et al.
Publicado: (2022)